Origin raises Series B funding to scale pelvic floor physical therapy nationwide
Bringing pelvic floor physical therapy into the mainstream
Origin, a US provider of pelvic floor physical therapy and women’s musculoskeletal care, has raised a Series B round led by SJF Ventures, as it seeks to expand access to a form of care long considered specialist, expensive and difficult to obtain.
The funding will support Origin’s effort to bring pelvic floor physical therapy into the mainstream, in a country where an estimated 41 million women live with pelvic floor-related conditions ranging from disruptive to debilitating. Women are also 50% more likely than men to experience musculoskeletal health concerns. Terms of the round were not disclosed.
“Pelvic floor physical therapy is the standard of care,” said Carine Carmy, Co-founder and CEO at Origin. “The data is clear: this effective, non-invasive therapy is the first line of treatment for dozens of women’s health issues, from postpartum recovery to incontinence.
“Origin’s specialized pelvic and musculoskeletal care has helped tens of thousands of patients reclaim their health, their confidence, and their quality of life. We’ve shifted pelvic floor therapy from niche to norm. This new round of funding will enable us to move it from norm to non-negotiable.”
Covering 50 million lives
Origin is a Los Angeles-based company which offers insurance-covered pelvic floor and full-body musculoskeletal (MSK) care through a hybrid model combining virtual appointments and in-person treatment at 19 clinics across seven states. Origin said it has treated more than 50,000 patients since launching in 2020 and now works with insurers covering around 50 million lives.
Pelvic floor dysfunction affects more than one in three women, rising to over half of women after the age of 55. Symptoms can include bladder or bowel incontinence, pelvic pain, painful sex and prolapse. Despite its prevalence, pelvic floor physical therapy remains underused in the US healthcare system, in part because care has historically been delivered through small, out-of-network clinics, with patients often paying hundreds of dollars per session.
Origin positions itself as a corrective to that model. The company said 95% of the care it delivers is in-network, with most patients paying less than $36 out of pocket per visit. Appointments are typically available within days, compared with waits of several months at many hospital-based services.
Origin’s clinical model centres on 45-minute, one-on-one sessions with licensed pelvic floor physical therapists or physical therapist assistants, delivered either virtually or in person. These visits are supported by a proprietary digital platform that provides tailored exercise programmes and educational resources between appointments. The company said nine in 10 patients report improvement in pelvic floor symptoms.
Alongside its care delivery model, Origin has invested heavily in technology. Drawing on longitudinal data from 39 million patient interactions over more than a decade, the company has developed an AI-driven clinical decision support product, known as Athena, designed to assist clinicians with patient assessment, care planning and regulatory compliance. It has also built a patient-facing AI agent to support ongoing care between visits.
Looking ahead
Origin said the new funding would allow it to accelerate product development, expand its clinic footprint, and invest further in clinical research and training. The company operates its own training and mentorship programme, Origin University, which trained more than 100 pelvic health physical therapists and assistants in 2025, more than double the previous year, as it seeks to address a national shortage of specialists in this field.
The round also included participation from Blue Venture Fund, Gratitude Railroad, the California Infrastructure and Economic Development Bank, and several angel investors, including Modern Fertility founder Afton Vechery and Spring Fertility founder Peter Klatsky.
For investors, the appeal lies in both unmet clinical need and system-level inefficiencies. According to Origin, pelvic floor dysfunction contributes to billions of dollars in avoidable healthcare costs each year, driven by delayed diagnosis, surgical interventions and fragmented care.
“For too long, pelvic floor conditions were overlooked or ignored,” said Perry Clarkson.
“Women seeking treatment had few care options, most of whom were not in network, and pelvic floor physical therapy was seen as niche and underutilised by referring providers.”
Origin said more than 10,000 doctors now refer patients to its services, up from 1,500 at the start of 2024. It has partnerships with major health systems including UCSF and The Woman’s Hospital of Texas, supporting patients through pregnancy, postpartum recovery and menopause.
The company was founded by Carmy alongside Nona Farahnik Yadegar and David Yadegar. Carmy has previously spoken about spending years seeking answers for pelvic pain before discovering pelvic floor physical therapy, an experience that helped shape Origin’s focus on access and insurance coverage.
The Series B comes as women’s health services continue to attract investor interest, particularly in areas where clinical standards of care are well established but unevenly delivered.